Find verified Cagrilintide API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Cagrilintide for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Cagrilintide API.
Alternate Names: GTPL13768, analogue 23 [PMID: 34288673], Cagrilintide [INN]
CAS No: 1415456-99-3
PubChem CID: 171397054
Mol Formula: C194H312N54O59S2
Mol Weight: 4409 g/mol
IUPAC Name: 20-[[(1S)-4-[[(2S)-6-amino-1-[[(4R,7S,10S,13S,16S,19R)-4-[[(2S)-1-[[(2S,3R)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[ -Show More
Therapeutic use: Antidiabetic agents
Commercial / Development Status: Under Development APIs
Source / Manufacturing Origin: Peptide APIs
API Description: Cagrilintide is under investigation in clinical trial NCT06221969 (A Research Study to See How Much Cagrisema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor). Cagrilintide is a long-acting analogue of amylin, developed primarily as a treatment for obesity and type 2 diabetes.
